英文名 | N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N-methyl-L-valyl-N-[(3R,4S,5S)-1-{(2S)-2-[(1R,2R)-3-{[(1S,2R)-1-hydroxy-1-phenyl-2-propanyl]amino}-1-methoxy-2-methyl-3-oxopropyl]-1-pyrrolidinyl}-3-methoxy-5-methyl-1-oxo-4-heptanyl]-N-methyl-L-valinamide |
---|---|
英文别名 |
L-Valinamide, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-N-methyl-L-valyl-N-[(1S,2R)-4-[(2S)-2-[(1R,2R)-3-[[(1R,2S)-2-hydroxy-1-methyl-2-phenylethyl]amino]-1-methoxy-2-methyl-3-oxopropyl]-1-pyrrolidinyl]-2-methoxy-1-[(1S)-1-methylpropyl]-4-oxobutyl]-N-methyl-
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N-methyl-L-valyl-N-[(3R,4S,5S)-1-{(2S)-2-[(1R,2R)-3-{[(1S,2R)-1-hydroxy-1-phenyl-2-propanyl]amino}-1-methoxy-2-methyl-3-oxopropyl]-1-pyrrolidinyl}-3-methoxy-5-methyl-1-oxo-4-heptanyl]-N-methyl-L-valinamide |
描述 | Fmoc MMAE是一种保护性基团共轭的单甲基奥斯汀E(MMAE),是一种有效的微管蛋白抑制剂。Fmoc MMAE可用于ADC的合成[1]。 |
---|---|
相关类别 | |
靶点 |
Auristatin |
参考文献 |
密度 | 1.1±0.1 g/cm3 |
---|---|
沸点 | 1036.4±65.0 °C at 760 mmHg |
分子式 | C54H77N5O9 |
分子量 | 940.22 |
闪点 | 580.6±34.3 °C |
精确质量 | 939.572144 |
LogP | 8.60 |
蒸汽压 | 0.0±0.3 mmHg at 25°C |
折射率 | 1.556 |